Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations

RATIONALE: C-reactive protein (CRP) is a systemic marker of inflammation that correlates with disease status in cystic fibrosis (CF). The clinical utility of CRP measurement to guide pulmonary exacerbation (PEx) treatment decisions remains uncertain. OBJECTIVES: To determine whether monitoring CRP d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ashutosh, Kirkpatrick, Gordon, Chen, Virginia, Skolnik, Kate, Hollander, Zsuzsanna, Wilcox, Pearce, Quon, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298271/
https://www.ncbi.nlm.nih.gov/pubmed/28178305
http://dx.doi.org/10.1371/journal.pone.0171229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298271/
https://www.ncbi.nlm.nih.gov/pubmed/28178305
http://dx.doi.org/10.1371/journal.pone.0171229

Ejemplares similares